Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Third-party passenger leukocytes prolong liver allograft survival.

Third-party passenger leukocytes prolong liver allograft survival. Transplant Proc. 2001 Feb-Mar; 33(1-2):171-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.